Sabine Bois
CEO since 2021 (employed by the company as CFO in 2014 and co-CEO since 2018).
Born 1980.
Education: MBA in Entrepreneurship and Finance, University of Wuppertal, Germany.
Background: Over 15 years of experience from the Biotech/Med-tech industry, among others from supporting the foundation of several successful start-ups within the research center and incubator “Caesar” in Bonn. Co-founding the biotech company Biosensor/SAW Instruments GmbH in 2007 (sold 2013).
Other current positions: –
Pascale Brasseur
Executive VP of Clinical Operations since 2023.
Born 1965.
Education: Master of Science in Health Economics from Université Claude Bernard in Lyon, France. Executive education (Advanced Strategy and Leadership Program), Wharton School of the University of Pennsylvania, USA
Background: 25 years of experience in health economics, outcomes research and reimbursement policy within the healthcare industry, with a unique perspective gained from working in both the medical device and pharmaceutical sectors. Among other experiences, a 15-year tenure at Medtronic leading market access activities for Cardiovascular in the EMEA Region and for Spine at a global level.
Other current positions: –
Johan Sundell
CFO since 2023.
Born 1971.
Education: Master of Science BA, Business Management from Lund University in Lund, Sweden.
Background: 25 years of experience in leading roles in finance with companies like BE Group Sverige and Brio AB. Most recently, Johan held the role as CFO of Caldic Nordics, a global solutions provider for innovative and sustainable solutions in life science and specialty chemicals.
Other current positions: –
Jose de la Cortina
CCO since 2022
Born 1973.
Education: Science Degree in Medical Biology from Université du Québec in Trois-Rivières, Canada, and a Commerce Degree in International Business from Concordia University in Montreal, Canada.
Background: 23 years of experience in the industry at Baylis Medical as a critical contributor to the huge success story of Baylis Medical that was acquired by Boston Scientific for 1.75 B USD$, by driving commercialization into the USA, Japan, Europe, and many other regions.
Other current positions: –
Jozef Bartunek
Chief Medical Officer (CMO) since 2022.
Born 1963.
Education: MD and PhD Faculty of Medicine, Cormenius University in Bratislava, Slovak Republic. Clinical and research cardiology fellowships Cardiovascular Center Aalst, Belgium, Beth Israel Deaconess Medical Center, Boston, MA.
Background: Practicing cardiologist with more than 25 years of experience combining expertise in interventional cardiology and heart failure. Research and innovation track in biologic and device-based interventions in heart failure and structural heart disease. Published more than 300 peer-reviewed articles as well as serves in editorial boards of several cardiovascular journals.
Other current positions: Associate Director, Cardiovascular Centre, OLV Hospital, Aalst, Belgium.
Mathias Bouzereau
Executive VP Global Marketing & Business Development since 2022.
Born 1971.
Education: Master of Business Administration from IMD Business School in Lausanne, Switzerland, a Master of Science in Computer Science from INSA Lyon, France, and the University of Nottingham, UK.
Background: 25 years of experience in the MedTech as well as High-Tech Solutions & Services Industry, bringing technology and business model innovation to market. Held several leadership positions in Europe and Latin America at Medtronic and Gemalto (now part of Thales), driving profitable growth in start-up, M&A and turnaround contexts.
Other current positions: –
Frank Dallmann
Executive VP Operations and R&D since 2023 (VP R&D since 2021).
Born 1969.
Education: Degree in Mechanical Engineering, Design and Product development from the Technical University in Dresden, Germany.
Background: 24 years of international experience in Operations and Research & Development of medical devices. Among other experiences as Head of Shoulder Development at Mathys Ltd. Bettlach in Germany and Switzerland.
Other current positions: –
Morwan Choli
Executive VP Regulatory Affairs & Quality since 2023.
Born 1976.
Education: Ph.D in Physics from Julius-Maximilian University Wuerzburg and Scientific background in Magnetic Resonance Imaging in cooperation with Forschungszentrum für Magnet-Resonanz-Bayern e.V. (MRB e.V) , Kopfklinik at University Hospital Heidelberg and St. Judes Children’s Research Hospital in Memphis.
Background: Extensive experience in regulatory certification processes in cooperation with different EU Notified Bodies. Has acted in several management roles and been responsible for an implantable device certification department in Germany as well as an overall medical device testing and certification division in Japan and Asia, supporting global medical device manufacturers.
Other current positions: –
Sakarias Lindell
Executive VP People & Culture since 2022.
Born 1981.
Education: Management and Behavioral Science, Scandinavian International University, Sweden
Background: 20 years experience from Medtech in various positions within sales and supply chain. Site Manager of Occlutech International, Management Consultant at Performax, Area Sales Manager at Olympus, Abbot Vascular and coach for the Swedish National Gymnastics Team.
Other current positions: –
Olga Hansson
Executive VP IT since 2024.
Born 1980.
Education:
Executive MBA, Business Management from Gothenburg University, Sweden. Master Degree in Linguistics and Psychology, Immanuel Kant State University of Russia.
Background: 20 years experience in leading roles in supply chain logistics, finance, customer service and IT/digital transformations within automotive, steel and paper industries. Worked for global companies including DFDS, Stora Enso and Geodis Wilson. For the past 10 years Olga held the role of IT director at Volvo Cars leading digitalization of Finance and Logistics departments on a global level
Other current positions: –